- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02301598
Femtosecond Laser-assisted Anterior Lamellar Keratoplasty
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Keratoplasty is the most widely spread tissue transplantation procedure. Although penetrating keratoplasty (PKP) is still commonly used for curing corneal dystrophy and opacities of different genesis, lamellar techniques provide significant advantages in terms of safety and predictability.
Al in all 13 FS-ALK procedures were performed for 11 eyes with advanced keratoconus and 2 eyes with superficial corneal scattering Before and after surgery uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), postoperative astigmatism, endothelial cell loss, central cornea thickness, residual recipient's tissue thickness, corneal hysteresis (CH) and corneal resistance factor (CFR) were evaluated . At 1-year follow-up Confoscan investigation of donor-recipient interface was performed.
All FS-ALK procedures were performed with Intralase FS 60kHz femtosecond laser in a following way. At first a 80% thickness corneal graft was prepared. Then maximum thickness recipients corneal dissection was performed according to OCT (optical coherence tomography) data and superficial tissue was removed. Transplant was fixed in a resulted bed by continuous suture.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Advanced keratoconus or stromal corneal scattering
- Normal endothelial cell density
Exclusion Criteria:
- Acute keratoconus in the anamnesis
- Low endothelial cell density
- Age under 18 years
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: FS-ALK
Femtosecond laser-assisted maximum thickness anterior lamellar keratoplasty (FS-ALK) was performed for 11 eyes of 11 patients with advanced keratoconus and 2 eyes of 2 patients with superficial corneal scattering.
|
The procedure was a non-penetrating transplantation of 80% thickness corneal graft
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Mean endothelial cell loss
Time Frame: 12 months after surgery
|
12 months after surgery
|
Mean postoperative astigmatism
Time Frame: 12 months after surgery
|
12 months after surgery
|
UCVA (uncorrected visual acuity)
Time Frame: 12 months after surgery
|
12 months after surgery
|
BSCVA (best spectacle-corrected visual acuity)
Time Frame: 12 months after surgery
|
12 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Corneal hysteresis
Time Frame: 12 months after surgery
|
Evaluation of biomechanical qualities of the cornea
|
12 months after surgery
|
Corneal resistance factor
Time Frame: 12 months after surgery
|
Evaluation of biomechanical qualities of the cornea
|
12 months after surgery
|
Central corneal thickness
Time Frame: 12 months after surgery
|
measured by OCT (optical coherence tomography - Optovue)
|
12 months after surgery
|
Residual recipient's tissue thickness
Time Frame: 12 months after surgery
|
measured by OCT (optical coherence tomography - Optovue)
|
12 months after surgery
|
Collaborators and Investigators
Investigators
- Study Director: Boris Malyugin, MD,PhD,prof., The S.N. Fedorof Federal State Institution
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FS-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Corneal Opacity
-
University of California, IrvineWithdrawnCORNEAL OPACITY WITH POOR PROGNOSIS FOR CORNEAL TRANSPLANTUnited States
-
Omar SaidCompletedCorneal OpacityEgypt
-
Oregon Health and Science UniversityNational Eye Institute (NEI); National Institutes of Health (NIH)Completed
-
United States Naval Medical Center, San DiegoActive, not recruitingCorneal OpacityUnited States
-
Oregon Health and Science UniversityNational Eye Institute (NEI); National Institutes of Health (NIH)Terminated
-
Federal University of São PauloUnknownKeratitis | Corneal OpacityBrazil
-
Oregon Health and Science UniversityNational Eye Institute (NEI); National Institutes of Health (NIH)Terminated
-
Baskent UniversityCompleted
-
University of UtahCompletedCorneal Opacity | Intraocular PressureUnited States
-
University Hospital, Strasbourg, FranceTerminatedKeratitis | Pterygium | Corneal Perforation | Corneal Opacity Corneal ThinningFrance
Clinical Trials on FS-ALK (Femtolaser-assisted anterior lamellar keratoplasty)
-
Oregon Health and Science UniversityNational Eye Institute (NEI); National Institutes of Health (NIH)Terminated
-
Istituto Internazionale di Ricerca e Formazione...Recruiting
-
Assiut UniversityNot yet recruitingCorneal Opacity | Keratoconus | Cornea
-
Hospital Oftalmologico de BrasiliaCompleted
-
Instituto de Oftalmología Fundación Conde de ValencianaCompletedKeratoconus
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityUnknownCorneal TransplantationChina